Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
GLP-1s can serve as a powerful complement to better lifestyle habits
Left thigh in the exact same spot every two weeks is not
Dr Paramesh Shamanna #Diabetes #Type2Diabetes #GLP1 #Tirzepatide #Semaglutide #Obesity #MetabolicHealth #Endocrinology #CGM #DiabetesRemission #Cardiometabolic To view or add a comment, sign in More Relevant Posts Day 49 / 365 Medicine of the Day: Rosuvastatin Drug Class: Statin (HMG-CoA Reductase Inhibitor) Lipid-lowering agent Indications / Uses: Hypercholesterolemia ( LDL-C) Mixed dyslipidemia Hypertriglyceridemia Prevention of cardiovascular events (MI, stroke) Familial hypercholesterolemia Mechanism of Action (MOA): Rosuvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis Cholesterol production in liver LDL cholesterol & triglycerides HDL cholesterol LDL receptor expression increased LDL clearance Dose: Usual starting: 1020 mg once daily Maintenance: 540 mg once daily Severe hypercholesterolemia: up to 40 mg/day Renal impairment: lower starting dose recommended Adverse Effects: Myalgia / muscle pain Elevated liver enzymes Headache Nausea Risk of rhabdomyolysis (rare) Slight increase in blood glucose Drug Interactions: Cyclosporine rosuvastatin levels Gemfibrozil risk of myopathy Warfarin anticoagulant effect Antacids (Al/Mg) absorption Protease inhibitors statin toxicity risk Contraindications: Active liver disease Pregnancy Breastfeeding Hypersensitivity Clinical Pearl: Rosuvastatin is one of the most potent statins with strong LDL-lowering ability and proven cardiovascular risk reduction, often effective at lower doses compared to other statins
Multiple factors can deplete glutathione levels, including: Aging: Glutathione levels naturally decline with age
A similar increased risk for heart failure was also observed for alogliptin (3.9% vs 3.3% for placebo)
J Clin Nurs Res (2022) 6:6775
